Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacoscintigraphic Investigation of Nevirapine Absorption
NCT02191189Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of nevirapine in human immunodeficiency virus infection (HIV) (5 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Area under the concentration-time curve of nevirapine in plasma over the time interval from 0 extrapolated to infinity up to 72 hours. Started May 2005; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02191189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191189.